Enveric Biosciences Inc expected to post a loss of 65 cents a share - Earnings Preview

Enveric Biosciences

09/08/2023 01:23

* Enveric Biosciences Inc  ENVB.OQ   ENVB.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 10 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Enveric Biosciences
Inc
is for a loss of 65 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Enveric
Biosciences Inc is $7​, above​ its last closing price of $2.72.
​​​

This summary was machine generated August 9 at 00:23 GMT.  All
figures in US dollars  unless otherwise stated